These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 19201936)
41. Issues and challenges for managed care in the treatment of asthma and chronic obstructive pulmonary disease. Schoening SK Am J Manag Care; 2004 Jul; 10(5 Suppl):S158-63. PubMed ID: 15354681 [TBL] [Abstract][Full Text] [Related]
42. Assessing the airways. Enright P; McCormack M Chron Respir Dis; 2008; 5(2):115-9. PubMed ID: 18539726 [TBL] [Abstract][Full Text] [Related]
43. Towards a better phenotyping of chronic obstructive pulmonary diseases. Spanevello A; Dragonieri S; Maestrelli P Respiration; 2009; 78(3):253-5. PubMed ID: 19609075 [No Abstract] [Full Text] [Related]
44. New roles for respiratory therapists: expanding the scope of practice. Merendino D; Wissing DR Respir Care Clin N Am; 2005 Sep; 11(3):543-55. PubMed ID: 16168920 [TBL] [Abstract][Full Text] [Related]
45. Inflammatory airway diseases and clinical allergy: inflammatory airways diseases and clinical allergy assembly contribution to the celebration of 20 years of the ERS. Joos GF; Barnes PJ Eur Respir J; 2010 Jun; 35(6):1197-9. PubMed ID: 20513906 [No Abstract] [Full Text] [Related]
47. Do family physicians' records fit guideline diagnosed COPD? Albers M; Schermer T; Molema J; Kloek C; Akkermans R; Heijdra Y; van Weel C Fam Pract; 2009 Apr; 26(2):81-7. PubMed ID: 19228813 [TBL] [Abstract][Full Text] [Related]
48. [Do we define the COPD correctly?]. de la Fuente Cid R; González Barcala FJ; Pose Reino A; Valdés Cudrado L An Med Interna; 2008 Jan; 25(1):41-3. PubMed ID: 18377196 [TBL] [Abstract][Full Text] [Related]
49. Differentiating the treatment of asthma and chronic obstructive pulmonary disease in the elderly patient. Davis E; Coover K; Morrow L; Malesker M Consult Pharm; 2012 Sep; 27(9):650-9. PubMed ID: 22982749 [TBL] [Abstract][Full Text] [Related]
50. Application of metabolomics approaches to the study of respiratory diseases. Snowden S; Dahlén SE; Wheelock CE Bioanalysis; 2012 Sep; 4(18):2265-90. PubMed ID: 23046268 [TBL] [Abstract][Full Text] [Related]
51. Reversibility testing in patients with asthma and COPD. Lynes D; Frankland K Nurs Stand; 2008 Sep 24-30; 23(3):45-9. PubMed ID: 18837279 [TBL] [Abstract][Full Text] [Related]
52. Psychiatric considerations in pulmonary disease. Shanmugam G; Bhutani S; Khan DA; Brown ES Psychiatr Clin North Am; 2007 Dec; 30(4):761-80. PubMed ID: 17938044 [TBL] [Abstract][Full Text] [Related]
54. Managed care viewpoint: the challenges of obstructive lung diseases. Orland BI Manag Care; 2005 Jul; 14(7 Suppl Obstructie Lung):5-8; discussion 24-6. PubMed ID: 18564558 [No Abstract] [Full Text] [Related]
55. Towards individualised medicine for airways disease: identifying clinical phenotype groups. Travers J; Weatherall M; Fingleton J; Beasley R Eur Respir J; 2012 Apr; 39(4):1033-4. PubMed ID: 22467724 [No Abstract] [Full Text] [Related]
56. Following Nero: fiddle while Rome burns, or is there a better way? Bush A; Pavord I Thorax; 2011 May; 66(5):367. PubMed ID: 21398374 [No Abstract] [Full Text] [Related]
57. [Possibilities of improving the diagnosis and treatment of obstructive pulmonary diseases in the Northern Administrative District of Moscow]. Shmeleva NM; Galkin IV; Sidorova VP; Belevskiĭ AS; Shmelev EI Probl Tuberk Bolezn Legk; 2008; (7):18-22. PubMed ID: 19110766 [TBL] [Abstract][Full Text] [Related]
58. Office management of COPD in primary care: a 2009 clinical update. Belfer MH Postgrad Med; 2009 Jul; 121(4):82-90. PubMed ID: 19641274 [TBL] [Abstract][Full Text] [Related]
59. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Agusti A; Sobradillo P; Celli B Am J Respir Crit Care Med; 2011 May; 183(9):1129-37. PubMed ID: 21169466 [TBL] [Abstract][Full Text] [Related]
60. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis. Koenig W Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]